Vitamin C and quinapril abrogate LVH and endothelial dysfunction in aortic-banded guinea pigs

被引:27
作者
Bell, JP
Mosfer, SI
Lang, D [1 ]
Donaldson, F
Lewis, MJ
机构
[1] Cardiff Univ, Dept Pharmacol Therapeut & Toxicol, Cardiff CF14 4XN, S Glam, Wales
[2] Cardiff Univ, Sir Geraint Evans Wales Heart Res Inst, Cardiff CF14 4XN, S Glam, Wales
来源
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY | 2001年 / 281卷 / 04期
关键词
ace inhibitors; antioxidant; left ventricular hypertrophy; endothelial function; oxygen-derived free radicals;
D O I
10.1152/ajpheart.2001.281.4.H1704
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Left ventricular hypertrophy (LVH) is a cardiovascular risk factor. A possible role for endothelial dysfunction in this condition was investigated in a Dunkin-Hartley guinea pig aortic-banded pressure overload-induced model of LVH. Aortic banding produced significant elevation of fore- and hindlimb blood pressure (BP), heart-to-body weight ratios, plasma angiotensin II (ANG II), endothelin-1 (ET-1), tumor necrosis factor-alpha. (TNF-alpha) levels, and coronary microvascular endothelial cell (CAMC) NAD(P)H-dependent superoxide (O-2(-)) production, and a significant decrease in basal and stimulated CMEC cGMP levels. Treatment of aortic-banded animals with the angiotensin-converting enzyme inhibitor quinapril and the antioxidant vitamin C, either alone or in combination, did not affect BP but caused a significant inhibition of the increases in the heart-to-body weight ratio, ANG II, ET-1, and TNF-alpha levels, and O-2(-) production and restored cGMP responses to levels comparable with sham-operated animals. These data suggest that quinapril and vitamin C are capable of inhibiting LVH development due to pressure overload via mechanisms that involve the inhibition of oxidative stress, an improvement in coronary endothelial function, and increased nitric oxide bioavailability.
引用
收藏
页码:H1704 / H1710
页数:7
相关论文
共 40 条
[1]   Modulation of angiotensin-converting enzyme by nitric oxide [J].
Ackermann, A ;
Fernández-Alfonso, MS ;
de Rojas, RS ;
Ortega, T ;
Paul, M ;
González, C .
BRITISH JOURNAL OF PHARMACOLOGY, 1998, 124 (02) :291-298
[2]   ENHANCEMENT OF LEFT-VENTRICULAR RELAXATION IN THE ISOLATED HEART BY AN ANGIOTENSIN-CONVERTING ENZYME-INHIBITOR [J].
ANNING, PB ;
GROCOTTMASON, RM ;
LEWIS, MJ ;
SHAH, AM .
CIRCULATION, 1995, 92 (09) :2660-2665
[3]   RENIN-ANGIOTENSIN SYSTEM INVOLVEMENT IN PRESSURE-OVERLOAD CARDIAC-HYPERTROPHY IN RATS [J].
BAKER, KM ;
CHERNIN, MI ;
WIXSON, SK ;
ACETO, JF .
AMERICAN JOURNAL OF PHYSIOLOGY, 1990, 259 (02) :H324-H332
[4]   RELEASE OF ENDOTHELIN FROM THE PORCINE AORTA - INHIBITION BY ENDOTHELIUM-DERIVED NITRIC-OXIDE [J].
BOULANGER, C ;
LUSCHER, TF .
JOURNAL OF CLINICAL INVESTIGATION, 1990, 85 (02) :587-590
[5]  
CORDER R, 1995, J CARDIOVASC PHARM, V26, pS56
[6]   Endothelial dysfunction in diabetes [J].
De Vriese, AS ;
Verbeuren, TJ ;
Van de Voorde, J ;
Lameire, NH ;
Vanhoutte, PM .
BRITISH JOURNAL OF PHARMACOLOGY, 2000, 130 (05) :963-974
[7]   Treatment of hypertension with ascorbic acid [J].
Duffy, SJ ;
Gokce, N ;
Holbrook, M ;
Huang, A ;
Frei, B ;
Keaney, JF ;
Vita, JA .
LANCET, 1999, 354 (9195) :2048-2049
[8]   On the role of vitamin C and other antioxidants in atherogenesis and vascular dysfunction [J].
Frei, B .
PROCEEDINGS OF THE SOCIETY FOR EXPERIMENTAL BIOLOGY AND MEDICINE, 1999, 222 (03) :196-204
[9]   Risk mechanisms in hypertensive heart disease [J].
Frohlich, ED .
HYPERTENSION, 1999, 34 (04) :782-789
[10]   NATRIURETIC PEPTIDES INHIBIT ANGIOTENSIN-II-INDUCED PROLIFERATION OF RAT CARDIAC FIBROBLASTS BY BLOCKING ENDOTHELIN-1 GENE-EXPRESSION [J].
FUJISAKI, H ;
ITO, H ;
HIRATA, Y ;
TANAKA, M ;
HATA, M ;
LIN, MH ;
ADACHI, S ;
AKIMOTO, H ;
MARUMO, F ;
HIROE, M .
JOURNAL OF CLINICAL INVESTIGATION, 1995, 96 (02) :1059-1065